摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-bis(acryloyl)-(L)-cystine | 161035-23-0

中文名称
——
中文别名
——
英文名称
N,N'-bis(acryloyl)-(L)-cystine
英文别名
N,N'-bisacryloylcystine;(2R)-3-[[(2R)-2-carboxy-2-(prop-2-enoylamino)ethyl]disulfanyl]-2-(prop-2-enoylamino)propanoic acid
N,N'-bis(acryloyl)-(L)-cystine化学式
CAS
161035-23-0
化学式
C12H16N2O6S2
mdl
——
分子量
348.401
InChiKey
YZDWFQPPSSVWAG-YUMQZZPRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    115-121 °C(Solv: acetone (67-64-1); ethyl ether (60-29-7))
  • 沸点:
    725.6±60.0 °C(Predicted)
  • 密度:
    1.412±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    22
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    183
  • 氢给体数:
    4
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    L-胱氨酸丙烯酰氯 在 sodium hydroxide 作用下, 以 甲醇 为溶剂, 生成 N,N'-bis(acryloyl)-(L)-cystine
    参考文献:
    名称:
    Functional, water-dispersible gold nanoparticles produced with N,N′-bis(acryloyl)-(l)-cystine
    摘要:
    功能性CiBA-AuNPs,具有与TSC-AuNPs相同的光学性能,用于交联反应时无需进行配体交换步骤。
    DOI:
    10.1039/c5ra16700k
点击查看最新优质反应信息

文献信息

  • Oxidation of ferrocenemethanol grafted to a hydrogel network through cysteine for triggering volume phase transition
    作者:Klaudia Kaniewska、Jan Romański、Marcin Karbarz
    DOI:10.1039/c3ra42405g
    日期:——
    New gels based on N-isopropylacrylamide and cysteine were prepared by free radical polymerization in aqueous solutions. To attach the amino acid to the polymer chain, its α-amino group was modified with acryloyl chloride and N,N′-bisacryloylcystine was obtained. Next, the disulfide bridges were reduced to thiol groups and the attachment of ferrocenemethanol to the chains was performed. The influence of the amount of electroactive groups and their degree of oxidation on the temperature of volume phase transition was investigated. The gel formed from the polymerization solution containing 2% N,N′-bisacryloylcystine could undergo the volume phase transition triggered by changing the ferrocene state of oxidation. The temperature window of the gel sensitivity to the oxidation state of its ferrocene component was 35–40 °C. During the transition the volume of the gel could be changed even by more than an order of magnitude. Thin layers of the electroactive and thermoresponsive gel could be anchored on the surface of a glassy carbon electrode. This was achieved by electroformation of radicals at the electrode surface. The influence of the volume phase transition triggered by a temperature change on redox processes of ferrocene moieties bound to the network was examined voltammetrically.
    基于N-异丙基丙烯酰胺和半胱氨酸的新凝胶通过水溶液中的自由基聚合制备。其中,为了将氨基酸连接到聚合链上,其α-氨基组通过丙烯酰氯进行了修饰,得到了N,N′-双丙烯酰半胱氨酸。接下来,将二硫键还原为巯基,并将铁马烯醇连接到链上。研究了电活性基团的数量及其氧化程度对体积相变温度的影响。含有2% N,N′-双丙烯酰半胱氨酸的聚合溶液形成的凝胶能够经历由铁马烯的氧化态变化引发的体积相变。该凝胶对其铁马烯成分氧化状态的敏感温度窗口为35-40°C。在相变过程中,凝胶的体积甚至可以改变一个数量级以上。电活性和热响应凝胶的薄层可以锚定在玻碳电极的表面。这是通过在电极表面电形成自由基实现的。通过伏安法研究了温度变化引发的体积相变对与网络结合的铁马烯基团的氧还原过程的影响。
  • DRUG DELIVERY SYSTEMS
    申请人:Biocompatibles Uk Ltd.
    公开号:EP2667855A1
    公开(公告)日:2013-12-04
  • EP2667855B1
    申请人:——
    公开号:EP2667855B1
    公开(公告)日:2017-08-09
  • Drug Delivery Systems
    申请人:Ashrafi Koorosh
    公开号:US20140030350A1
    公开(公告)日:2014-01-30
    The present invention relates to microparticles comprising a gel body, wherein the gel body comprises a synthetic polymer and a drug, wherein the microparticles have an average diameter in the range 40 to 1500 μm, wherein the polymer is cross-linked by groups comprising disulfide linkages and is in the form of a hydrogel.
  • [EN] DRUG DELIVERY SYSTEMS<br/>[FR] SYSTÈME D'ADMINISTRATION DE MÉDICAMENTS
    申请人:BIOCOMPATIBLES UK LTD
    公开号:WO2012101455A1
    公开(公告)日:2012-08-02
    The present invention relates to microparticles comprising a gel body, wherein the gel body comprises a synthetic polymer and a drug, wherein the microparticles have an average diameter in the range 40 to 1500 µm, wherein the polymer is cross-linked by groups comprising disulfide linkages and is in the form of a hydrogel.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物